chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After 24 hours, I started having body aches, that night couldn't sleep I took Ibuprofen it helped, over the weekend I kept taking Ibuprofen. Monday my tongue and half of head was sensitive and weird, it kind of hurt to rub through my hair and tongue felt like pins and needles this lasted through Thursday, and that morning woke up wit a lump behind my ear, I went to clinic, the doctor or PA diagnosed me with shingles, but I don't have any sores, he gave me a prescription but the next morning I woke up and notice i lost facial control on left side, could blink or close mouth on left side. I went to clinic and they diagnosed me with  Bells Palsy and gave me a prescription for steroids and that was last Friday and its been a week that I've been on these meds. The main problem is the Bells Palsy has made my left side not work, dizziness,  pain down my neck, the lump behind my ear finally went away after a week but the paralysis on the left side of my face is still there and the dizziness. I was having headaches but stayed on top of it with Advil and today I go back to clinic for a follow up appointment.
Presented to ED w/gen weakness, fatigue & SOB; pt dx w/ COVID in ED day prior but d/t no improvement, pt returned; admitted 10/25 for COVID-19 infection & hypoxia; 10/25 - tx w/antibiotics, steroids,Vit C, zinc; 10/27 - added remdesivir; pt became increasing hypoxic & maxed out on BIPAP and was intubated 10/2, extubated 10/30.Pt weaned down to RA at DC.
July 17 2023 patient received Prevnar 20, July 24th patient came in to receive Shingrix, indicated that after she received her Prevnar20, she had swelling from neck to the top of left shoulder.  Indicated she took ibuprofen and the swelling went down.  Shingrix given 07/24/23, patient called approximately 2 hours after and indicated she was itching all over her body but no rash.  Asked if she could take Benadryl to help with the itching.  Patient was also instructed to follow up with her provider and that a report would be submitted.  Pharmacist also tried to follow up with doctors office,  but had to leave a voicemail.
Right deltoid area non-tender, moderate swelling with 8.5cmx7.5cm erythema.
On 11/28/19 I started to develop  signs of rashes on both of my arms (area inside my forearms), the bottom of my buttocks and in and around my crotch area.  Today is 12/1/19. I did not contact my doctor or go to urgent care as of yet only because I wanted to see if it will go away on it?s own. Overall I feel ok, I?m not having not having any breathing issues and I?m sleeping well.
Approximately 2.5 weeks after administration of GARDASIL in normal, healthy adult male, age 26, patient described ear pain and taste changes -metallic taste on left side of tongue. Three days later patient has physical symptoms with a diagnosis of BELL's Palsy resulting in left facial paralysis. At the time of this report, symptoms have not resolved and patient has had physical symptoms of BELL's Palsy for 5 days.
first 24 hours typical reaction, feverish body aches after 24 hours developed swelling to rt clavicle region, swelling has persisted for a few days
CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; This spontaneous report received from a patient via other manufacture Pfizer concerned a 64 year old male of unspecified race and ethnicity. Initial information was processed along with the additional information received on 16-MAY-2022. The patient's height, and weight were not reported. The patient's concurrent conditions included: overweight, and asthmatic. On an unspecified date, the patient previously received with covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown) dose was not reported, 1 total, administered for prophylactic vaccination. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26. cov2.s (dose number in series 1).  On an unspecified date in NOV-2021, the patient additionally received booster covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: 211D31A, expiry: unknown) 1 total, dose was not reported for prophylactic vaccination. Concomitant medications included ascorbic acid, ergocalciferol, and zinc.  On an unspecified date, patient experienced very mild symptoms as mild and itchy cough and was prescribed with Paxlovid. On 04-MAY-2022 (in the night, day before reporting), he had stuffy nose. The patient reported that he was out in some weather that was cold and raining that maybe aggravated the covid . The patient also reported that he had not started the Paxlovid till the time of reporting and he had a stuffy nose before starting the Paxlovid (confirmed covid-19 infection) (dose number in series 2). Laboratory data (dates unspecified) included: Covid-19 virus test positive (confirmed clinical vaccination failure) Positive (dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from confirmed covid-19 infection, and the outcome of confirmed clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with a product quality complaint: 90000230986.; Sender's Comments: V0 : 20220523540-covid-19 vaccine ad26.cov2.s-confirmed clinical vaccination failure. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS. Therefore, this event(s) is considered not related.
pt recv vax SEP97 & SEP97 approx 2wk p/vax pt exp rash;
Information has been received from a nurse practitioner concerning a patient who was vaccinated with a dose of ZOSTAVAX vaccine (Oka/Merck) (lot number, injection site and route not reported). Subsequently the patient experienced shingles. The patient went to the doctor's office and sought unspecified medical attention. No product quality complain was involved.
pain on the injection site; he states that the vaccination provider squeezed the area where he received the second dose; This is a spontaneous report from a contactable consumer .     A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in Arm on 09Apr2021 (Lot number was not reported) as single dose for covid-19 immunisation.The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number was not reported) via an unspecified route of administration, on an unspecified date as single dose for covid-19 immunisation. He said when he got the 2nd dose, the one who injected the vaccine squeezed his arm. He reported that the arm should not be squeezed if the vaccine will be administered, he wants to know if that's true and if there would be a problem with the vaccine administered since his arm was squeezed and reported that the 2nd dose seems to have no effect. He said he felt the needle when it was administered, but he only felt a little pain on the injection site, but no other side effects. He wants to confirm if he really got the 2nd dose of the vaccine. On an unspecified date, the patient experienced pain on the injection site and he states that the vaccination provider squeezed the area where he received the second dose. Outcome of the events was unknown.  No Follow-up attempts are needed. Information about lot/batch number cannot be obtained.
pt exp a red area the size of a quarter @ the inject site & c/o  soreness & puffiness.  22aug96 red area was size of a silver dollar & felt hot. pt continued to have soreness @ site. 24aug96 child awoke c/o pain &red streak down to el
Ringing in my left ear (Tinnitus). It is nonstop now for three weeks. I have never had it before.
ACHY; FEVER; TIRED NAPPED FOR TWO DAYS ON AND OFF; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced achy, fever, and tired napped for two days on and off. The action taken with covid-19 vaccine was not applicable. The outcome of the fever, achy and tired napped for two days on and off was not reported. This report was non-serious.
SIGNIFICANT PAIN FROM LEFT SHOULDER BLADE DOWN TO WRIST.  LIMITED RANGE OF MOTION.
Follow up: Patient received casirivimab instead of intended COVID vaccine.  At 48-hr follow up revealed patient experienced Headache.  Patient received COVID vaccine on December 31
Since may 27 I have had trouble keeping awake during the day.  Hard to get out of bed after waking.  Brain fog.  Extreme fatigue.  Muscle and joint pain. Cough
Arm pain at injection site; general body aches; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), Lot: EK 5930, intramuscularly on 30Dec2020 11:30 (at the age of 48-years-old), as a single dose in the left arm for COVID-19 immunization. Medical history included penicillin and cephalosporins allergy, possible Behcet's Syndrome, allergies and COVID-19 (diagnosed prior to the vaccination). The patient was not pregnant at the time of vaccination. Concomitant medications were not reported; however, it was reported that the patient received unspecified medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. The patient previously took codeine and experienced allergies. On 30Dec2020 at 20:00 on the second day (as reported), the patient experienced arm pain at the injection site and general body aches. The patient did not receive treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the arm pain at the injection site and general body aches was resolving.
This spontaneous report has been received from a nurse practitioner regarding a patient of unknown age or gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated VARIVAX dose 1, (dose, lot # and expiry date unknown). On 21-FEB-2011, patient received improperly stored VARIVAX dose 2, from lot # 666869/0469Z expiry date 31-MAR-2012.  No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review and records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one of several reports received from the same reporter. Additional information has been requested.
Patient has had a red arm, swelling under the arm for a couple of days. Arm is warm to the touch
I RECEIVED MY VACCINE AT APPROX 9:45 AM AT THE vaccination site.     I WAITED IN THE HIGH RISK AREA FOR APPROX 45 MINUTES UNTIL 10:30 A.M.  APPROX 15 MINUTES AFTER LEAVING THE vaccination site HIGH RISK WAITING AREA, THE REACTION SYMPTONS STARTED (APPROX 10:45 A.M.)  THE SYMPTONS STARTED AS WATERY AND ITCHY EYES AND THEN SWELLING - MY RIGHT EYE WAS COMLETELY SHUT WITHIN APPROX 30 MINUTES OF ONSET SYMPTOMS.   MY LEFT EYE DID NOT SWELL COMPLETELY SHUT.
Swollen lymph nodes on Left clavicle (same side of injection), tingling, "icey-hot" sensation on L side of neck down to clavicle. A sore appeared on my gum on left side, sore throat; felt sick, headache, runny nose (sniffles); feel tired and no energy, loose stool, outbreak of (vaginal) herpes that I haven't had in a long time.
On 8/4/11 pt's mother called Dr relating pt had erythema and swelling of bil arms - admitted to hospital given IV Ceftriaxone and SOLU MEDROL symptoms improved. Pt discharged 8/5/11. Symptoms came back - induration and redness over injection sites, fever, face flushing, admitted to hospital 8/6/11 - observed overnight discharged 8/7/11.
Diaphoretic, body aches, dry cough, low grade fever. Petechiae bilaterally lower legs and to po & feet. HTN.
developed rash at site of Zostavax 2x3cm local treatment  Developed tenderness at site of Pneumovax
Pt. presents with complaints of ( R ) arm pain/swelling at injection site area. ( R ) delt/upper arm swollen, warm to touch, lg area upper arm reddened. Pt. noted yesterday small amt redness-now has spread to lger area. Also nausea/vomiting thru night.
SEIZURES; This spontaneous report received from a pharmacist concerned multiple patients of unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no medical history. The patients received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported, 1 total for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, pharmacist called for a follow up on a precious case, wherein the 2 patients experienced seizures after getting J and J vaccine with no medical history, while speaking to nurse she mentioned there was total 4 cases, total 2 patients on 3-Jun-2021 and a week prior was other patient and patient on 12-Jun-2021, all experienced seizures. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of seizures was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210629430.; Sender's Comments: V0:20210638870-covid-19 vaccine ad26.cov2.s -Seizures. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Tired; Chills; like the flu; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tired), CHILLS (Chills) and INFLUENZA LIKE ILLNESS (like the flu) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 080M20A) for COVID-19 vaccination.     Concurrent medical conditions included Emphysema, COPD, Blood pressure, Aneurysm and Oxygen consumption.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Tired), CHILLS (Chills) and INFLUENZA LIKE ILLNESS (like the flu). At the time of the report, FATIGUE (Tired), CHILLS (Chills) and INFLUENZA LIKE ILLNESS (like the flu) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  Second dose has taken on 11-Mar-2021.  No treatment medications were provided.   This case was linked to MOD-2021-352745 (Patient Link).
fever, chills, body aches, loss of appetite started at 4PM and continued to progress through night and next AM
got singled from the shot/ suspected Vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   The reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient's brother/sister. The age at vaccination was not reported. The patient got shingles from the Shingles shot and had problems for two years. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
Bexsero vaccine was given at approximately 3:00 pm 5/23. Within 30 minutes to one hour, he began to feel bad and developed a fever of 102.5 degrees (oral). 400 mg Ibuprofen was given and the fever reduced to 101. He was lethargic and had chills and body aches. The high fever returned within a few hours and Ibuprofen was given every 6 hours around the clock (5/23-5/26). Late day, 5/2, he no longer had a fever but still felt very lethargic and unwell until the morning of 5/27.  Approximately 72 hours with fever and symptoms. The adverse reaction was reported on 5/24 to his doctor's office and again on 5/25 when his symptoms had not resolved.
Patient stated he became ill and suffered syncope a day after receiving the vaccine. He experienced what he described as palpitations. He went to the ER and given an EKG and "tests". The findings did not indicate any type of dysrhythmia. He was referred to a cardiologist appointment for next week as a follow-up and precaution.
chills; high fever; fatigue; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (high fever), FATIGUE (fatigue) and ARTHRALGIA (joint pain) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHILLS (chills), PYREXIA (high fever), FATIGUE (fatigue) and ARTHRALGIA (joint pain). At the time of the report, CHILLS (chills), PYREXIA (high fever), FATIGUE (fatigue) and ARTHRALGIA (joint pain) outcome was unknown. Not Provided          Concomitant medication was not provided Treatment information was not provided    This case was linked to US-MODERNATX, INC.-MOD-2021-011440 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-011440:First dose
The day following the vaccine I started to feel cold. I left work to go home. My temp was 101. I had a severe headache that affected the back of my head and neck. My arm was so sore I couldn't even lift it. I took Tylenol but it didn't really help the symptoms. This all lasted about 10 hours. When I woke up the next day everything was back to normal. On 03/05/2022 I thought I had allergies. I had an itchy throat, headache, sneezing. The night of 03/08/2022 my temp was 100.7. I took Tylenol and went to bed. When I woke up my temp was 100.5. I went to see my doctor and she sent me home to do a home COVID test. It came back positive. I took a home test on 03/17/2022 and it came back negative. I did go to urgent care on 03/20/2022 to be retested and it confirmed a negative result.
Patient report that at 3am 11/2/07 she experienced vomiting, diarrhea, chills and has 3-4 more bouts of vomiting and diarrhea into the day. She was not able to eat anything on 11/2 and did not go to work on 11/2 and 11/3. She reported these events to me today 11/7. She no long has vomiting or diarrhea but still does not feel well.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 01Oct2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 71 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing), notes: Other medical history: High blood pressure; "Obesity" (unspecified if ongoing), notes: Other medical history: obesity. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 from 27Dec2022 to 31Dec2022.  Clinical information : It was reported as, No known allergies.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Numbness and tingling in back and down upper and lower extremities Sensation of coldness across back (area below neck and across shoulders blades) and down upper and lower extremities
FEELING DIZZINESS THE WHOLE WEEK; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025, and expiry: UNKNOWN) dose was not reported, administered on 13-MAR-2021 at left deltoid for prophylactic vaccination. No concomitant medications were reported. On 16-MAR-2021, the subject experienced feeling dizziness the whole week. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from feeling dizziness the whole week. This report was non-serious.